Risk of cardiac valve disorders associated with the use of biphosphonates (Cardiac valve disorders and biphosphonate use)First published 06/06/2012 Last updated 02/07/2024 EU PAS number: EUPAS2616StudyFinalised
The PHARMO Institute for Drug Outcomes Research (PHARMO Institute)Netherlands First published: 07/01/2022Last updated 24/07/2024 InstitutionLaboratory/Research/Testing facilityENCePP partner